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Abstract: Objective: To prove intra- and inter-observer’s reliability of ultrasound (US) in the assessment of lipoatrophic 
findings related to the HIV associated Adipose Redistribution Syndrome (HARS). 
Patients and Methods: In two separated sessions, 2 consecutive measurements of subcutaneous fat thickness (SFT) were 
performed by each observer at the deepest point of Bichat pad, the dorsal face of arm and the mid thigh for the assessment 
of facial, brachial and crural lipoatrophy, respectively. We enrolled 20 HIV patients, rotating an experienced and un-
trained sonologist. The assessments were performed avoiding any stand off pads in the skin and excluding artefacts due to 
the too abundant quantity of gel to obtaining, with minimal transducer pressure, the best resolution of the reference points. 
Results: Means of facial, brachial and crural SFT showed no significant differences between the workers. Coefficients of 
variability (SD/mean x100) were similar for facial (ranges: 4.7-5.2% vs 4.9-5.6%, respectively), brachial (ranges: 5.8-
8.4% vs 9.7-11.2%) and crural SFTs (ranges: 5.9-6% vs 6.2-8.7%). There was greater consistency in the measurements 
performed by the experienced vs the untrained worker. Inter-observer agreement, assessed through kappa statistic (k) 
analysis, confirmed increased measurement’s agreement in the facial (k ranged from 0.40 to 0.60), brachial (k: 0.23-0.63) 
and crural SFT assessments (k: 0.58-0.70) from the 1
st
 to 2
nd
 session. 
Conclusions: US shows low intra observer variability and good inter observer reliability in the assessment of body fat 
changes related to the HARS. The different degree of consistency by the workers and the improvement of interobserver 
agreement, suggest to stating a well defined period of training to obtain  better US reliability. 
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 We read the interesting report by Padilla et al. [1] about 
the use of ultrasound (US) in assessing of body fat changes 
(BFCs) related to HIV associated Adipose Redistribution 
Syndrome (HARS) [2, 3]. 
 The authors confirm the good accuracy of US [4-10], fur-
ther validating our opinion that the routine US assessment of 
related to antiretroviral (ARV) therapy should be part of the 
standardized procedures in the care of HIV patients. How-
ever, some open questions stay on: 
1) Computed tomography (CT) is the gold standard tool 
for the BFCs assessments based on its low variability 
and high accuracy [11, 12]. Anyhow, recent reports 
[4-10] have demonstrated the utility of alternative 
methods such as US, that are easier to perform and 
more readily available both of which are valuable as-
sets when close follow up is required. 
 During the 12th Conference on Retroviruses and Op-
portunistic Infections, i.e., Moyle et al. reported the 
ability of US to document the recovery of malar  
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subcutaneous fat thickness (SFT) at deepest point of 
Bichat pad in patients who had been switched to less 
invaliding new generation of ARVs, using 6 months 
re-assessments which are not readily feasible with 
CT. 
2) Interestingly, in the few studies that have compared 
US with CT in measuring SFT [1, 13] the methods 
proved comparable; however the authors obtained 
controversial results when assessing malar SFT at the 
deepest point of Bichat pad [1]. We feel that the ques-
tion of measurement’s technique is crucial to explain 
these results. Based on our measurement’s technique, 
i.e., our data suggest high comparability between the 
CT and US measurements of SFT at reference points 
(RPs) representative of facial, brachial and crural 
lipoatrophy (LA) (Fig. 1a-c) [14]. 
3) Proven, reliable and well standardized RPs have been 
validated for brachial and crural LA [9], as well as 
confirmed also by Padilla et al. [1]. The RP for facial 
LA is more controversial. 
 In previous reports [8] we observed that US scannings 
of deepest point of Bichat’s pad provide reliable evi-
dence for diagnosing of facial SAT loss (Fig. 1a). In 
our investigation we are observing good accuracy of  
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Fig. (1).  Sonographic reference points for the assessment of subcu-
taneous fat thickness related to the body fat changes described in 
the HARS. US scan with 7.5-13 MHz linear transducers is per-
formed with no pressure on the underlying skin. (A) Facial LA: 
SFT is measured with a left nasogenian transversal scan from the 
malar bone (MB) to the hyperechoic line corresponding to corneous 
layer of epidermidis (S) on deepest point of Bichat pad (BP). (B) 
Brachial LA: SFT is measured with a long scans 10 centimetres 
above the right elbow from superficial fascia of triceps muscle (T 
M) upper omeral bone (OB) to the hyperechoic line corresponding 
to corneous layer of epidermidis (S). (C) Crural LA: SFT is meas-
ured with long scans 15 centimetres above the rotula, from superfi-
cial fascia of quadriceps muscle (QM) upper the femoral bone (B) 
to the hyperechoic line corresponding to corneous layer of epider-
midis (S). 
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Fig. (2). Intra observer variability of Experienced and Untrained 
Sonologist in the sonographic measurements of subcutaneous fat 
thickness. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (3). Inter rate agreement (kappa) between the Sonologists in 
the single sessions. The agreement was quantified by the kappa (k) 
statistic: k is 1 when there is perfect agreement between the classi-
fication system; 0 when there is no agreement better than chance; 
the strength of agreement is poor when k<0.20, fair when k<0.40, 
moderate when k<0.60, good with k<0.80, excellent with k>0.80. 
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this facial SFT measurement’s technique and it seem 
to correctly diagnose high percentages of facial LA 
compared to the clinical assessments. The high level 
of agreement with the CT assessments suggests that it 
is simple and more reliable than more peripheral RPs 
[6, 8]. 
4) Therefore, although the authors [1], that assessed the 
same RP, shows disappointing results, we feel that a 
not optimized measurement’s technique could have 
influenced their results. This opinion is strengthened 
by the high intra- and inter-observer variability re-
ported by Padilla et al. [1] (~ 31% and 32%, respec-
tively based on 6 assessments by 3 radiologists for 
only 2 patients) as compared to that observed in other 
studies (2.6-3.5%) [9]. We investigated intra and in-
ter-observer’s variability of facial, brachial and crural 
SFT assessments made by an experienced and an un-
trained sonologist. Each sonologist performed 3 con-
secutive measurements of 20 lipoatrophic patients 
during two separate sessions, using an EUB 8500 
(HITACHI Medical System). Coefficients of variabil-
ity (SD/mean x100) were similar for the facial 
(ranges: 4.7-5.2% vs 4.9-5.6%, respectively), brachial 
(range 5.8-8.4% vs 9.7-11.2%) and crural SFTs 
(ranges 5.9-6% vs 6.2-8.7%). There was greater con-
sistency in the measurements performed by the expe-
rienced vs the untrained worker suggesting the need 
for standardized training to achieve the better reliabil-
ity (Fig. 2a,b). 
 Inter-observer agreement as assessed by means of kappa 
statistic (k) analysis confirmed increased measurement 
agreement in the assessments of facial (k ranged from 0.40 
to 0.60), brachial (k: 0.23-0.63) and crural RP (k: 0.58-0.70) 
from the 1
st
 to the 2
nd
 session with definitive good agreement 
(Fig. 3). We are currently enlarging our experience in a mul-
ticentric study with similar encouraging reports on the effi-
cacy of training performed by the same experienced teacher. 
 In conclusion, if several reports [4-10] show that US can 
be used to accurately identify HARS-related BFCs, the use 
of a well-defined and standardized measurement technique is 
required in order to optimize the reliability and utility of US-
mediated BFC assessment, beginning with the careful identi-
fication and measurement of RPs, avoiding any bias such as 
the pressure offered by stand off pads in the skin, and taking 
care in excluding artefacts due to the too abundant quantity 
of gel in order to obtain, with minimal transducer pressure, 
the best resolution of RPs such as indicated in Fig. (1). 
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